ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.

Several studies have suggested ERBB3/HER3 may be a useful prognostic marker for colorectal cancer. Tumours with an intestinal stem cell signature have also been shown to be more aggressive. Here, we investigate whether ERBB3 is associated with intestinal stem cell markers in colorectal cancer and if...

Full description

Bibliographic Details
Main Authors: Thierry Jardé, Lisa Kass, Margaret Staples, Helen Lescesen, Peter Carne, Karen Oliva, Paul J McMurrick, Helen E Abud
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4569358?pdf=render
_version_ 1819240029000564736
author Thierry Jardé
Lisa Kass
Margaret Staples
Helen Lescesen
Peter Carne
Karen Oliva
Paul J McMurrick
Helen E Abud
author_facet Thierry Jardé
Lisa Kass
Margaret Staples
Helen Lescesen
Peter Carne
Karen Oliva
Paul J McMurrick
Helen E Abud
author_sort Thierry Jardé
collection DOAJ
description Several studies have suggested ERBB3/HER3 may be a useful prognostic marker for colorectal cancer. Tumours with an intestinal stem cell signature have also been shown to be more aggressive. Here, we investigate whether ERBB3 is associated with intestinal stem cell markers in colorectal cancer and if cancer stem cells within tumours are marked by expression of ERBB3. Expression of ERBB3 and intestinal stem cell markers (LGR5, EPHB2, CD44s and CD44v6) was assessed by qRT-PCR in primary colorectal tumours (stages 0 to IV) and matched normal tissues from 53 patients. The localisation of ERBB3, EPHB2 and KI-67 within tumours was investigated using co-immunofluorescence. Expression of ERBB3 and intestinal stem cell markers were significantly elevated in adenomas and colorectal tumours compared to normal tissue. Positive correlations were found between ERBB3 and intestinal stem cell markers. However, co-immunofluorescence analysis showed that ERBB3 and EPHB2 marked specific cell populations that were mutually exclusive within tumours with distinct proliferative potentials, the majority of ERBB3+ve cells being non-proliferative. This pattern resembles cellular organisation within normal colonic epithelium where EPHB2 labelled proliferative cells reside at the crypt base and ERBB3+ve cells mark differentiated cells at the top of crypts. Our results show that ERBB3 and intestinal stem cell markers correlate in colorectal cancers. ERBB3 localises to differentiated cell populations within tumours that are non-proliferative and distinct from cancer stem cells. These data support the concept that tumours contain discrete stem, proliferative and differentiation compartments similar to that present in normal crypts.
first_indexed 2024-12-23T14:01:31Z
format Article
id doaj.art-111cb834b2f44a5ebc20762dc102661a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T14:01:31Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-111cb834b2f44a5ebc20762dc102661a2022-12-21T17:44:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01109e013833610.1371/journal.pone.0138336ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.Thierry JardéLisa KassMargaret StaplesHelen LescesenPeter CarneKaren OlivaPaul J McMurrickHelen E AbudSeveral studies have suggested ERBB3/HER3 may be a useful prognostic marker for colorectal cancer. Tumours with an intestinal stem cell signature have also been shown to be more aggressive. Here, we investigate whether ERBB3 is associated with intestinal stem cell markers in colorectal cancer and if cancer stem cells within tumours are marked by expression of ERBB3. Expression of ERBB3 and intestinal stem cell markers (LGR5, EPHB2, CD44s and CD44v6) was assessed by qRT-PCR in primary colorectal tumours (stages 0 to IV) and matched normal tissues from 53 patients. The localisation of ERBB3, EPHB2 and KI-67 within tumours was investigated using co-immunofluorescence. Expression of ERBB3 and intestinal stem cell markers were significantly elevated in adenomas and colorectal tumours compared to normal tissue. Positive correlations were found between ERBB3 and intestinal stem cell markers. However, co-immunofluorescence analysis showed that ERBB3 and EPHB2 marked specific cell populations that were mutually exclusive within tumours with distinct proliferative potentials, the majority of ERBB3+ve cells being non-proliferative. This pattern resembles cellular organisation within normal colonic epithelium where EPHB2 labelled proliferative cells reside at the crypt base and ERBB3+ve cells mark differentiated cells at the top of crypts. Our results show that ERBB3 and intestinal stem cell markers correlate in colorectal cancers. ERBB3 localises to differentiated cell populations within tumours that are non-proliferative and distinct from cancer stem cells. These data support the concept that tumours contain discrete stem, proliferative and differentiation compartments similar to that present in normal crypts.http://europepmc.org/articles/PMC4569358?pdf=render
spellingShingle Thierry Jardé
Lisa Kass
Margaret Staples
Helen Lescesen
Peter Carne
Karen Oliva
Paul J McMurrick
Helen E Abud
ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.
PLoS ONE
title ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.
title_full ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.
title_fullStr ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.
title_full_unstemmed ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.
title_short ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.
title_sort erbb3 positively correlates with intestinal stem cell markers but marks a distinct non proliferative cell population in colorectal cancer
url http://europepmc.org/articles/PMC4569358?pdf=render
work_keys_str_mv AT thierryjarde erbb3positivelycorrelateswithintestinalstemcellmarkersbutmarksadistinctnonproliferativecellpopulationincolorectalcancer
AT lisakass erbb3positivelycorrelateswithintestinalstemcellmarkersbutmarksadistinctnonproliferativecellpopulationincolorectalcancer
AT margaretstaples erbb3positivelycorrelateswithintestinalstemcellmarkersbutmarksadistinctnonproliferativecellpopulationincolorectalcancer
AT helenlescesen erbb3positivelycorrelateswithintestinalstemcellmarkersbutmarksadistinctnonproliferativecellpopulationincolorectalcancer
AT petercarne erbb3positivelycorrelateswithintestinalstemcellmarkersbutmarksadistinctnonproliferativecellpopulationincolorectalcancer
AT karenoliva erbb3positivelycorrelateswithintestinalstemcellmarkersbutmarksadistinctnonproliferativecellpopulationincolorectalcancer
AT pauljmcmurrick erbb3positivelycorrelateswithintestinalstemcellmarkersbutmarksadistinctnonproliferativecellpopulationincolorectalcancer
AT heleneabud erbb3positivelycorrelateswithintestinalstemcellmarkersbutmarksadistinctnonproliferativecellpopulationincolorectalcancer